Smew Awad I, Lundholm Cecilia, Gong Tong, Lichtenstein Paul, Sävendahl Lars, Almqvist Catarina
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.
J Clin Endocrinol Metab. 2025 Jul 15;110(8):e2765-e2777. doi: 10.1210/clinem/dgae809.
Normal growth throughout childhood and adolescence is considered an indicator of adequate glycaemic control in patients with type 1 diabetes. While it has been suggested that growth in type 1 diabetes is reduced, the literature is conflicting and differences in final adult height and the risk of short stature depending on glycaemic control remain largely unexplored.
This work aims to assess adult height outcomes across levels of glycemic control in children and adolescents with type 1 diabetes, as well as to investigate the effect of sex, age at disease onset, and timing of glycemic control in relation to puberty.
In this population-based Swedish cohort study, we collected data on glycemic control and height from specialist health-care visits of all individuals with childhood-onset type 1 diabetes in the National Diabetes Register. Using linear and logistic regression, we compared suboptimal (glycated hemoglobin A1c [HbA1c] 53-75 mmol/mol [7.0-9.0%]) and poor (HbA1c > 75 mmol/mol [>9.0%]) to optimal (HbA1c < 53 mmol/mol [<7.0%]) glycemic control in relation to final adult height and the risk of short stature.
Poor glycemic control was associated with lower final adult height (-2.91 cm [95% CI, -3.48 to -2.33] for males, -1.83 cm [-2.42 to -1.23] for females) as well as a higher risk of short stature in males (odds ratio 1.90 [1.07-3.35]) but not in females (0.73 [0.36-1.51]). For females, adult height was lower only among those with type 1 diabetes since before puberty and if the poor glycemic control occurred before puberty. For males, adult height was lower irrespective of their age at diabetes onset, but only if they had poor glycemic control during or after puberty.
Poor glycemic control after the onset of type 1 diabetes, compared to optimal control, is associated with lower adult height in males and females. The prepubertal period seems to be more critical for females than males.
儿童和青少年时期的正常生长被视为1型糖尿病患者血糖控制良好的一个指标。虽然有人提出1型糖尿病患者的生长发育会减缓,但相关文献存在矛盾之处,而且关于最终成人身高以及根据血糖控制情况而定的身材矮小风险差异在很大程度上仍未得到充分研究。
这项研究旨在评估1型糖尿病儿童和青少年不同血糖控制水平下的成人身高结果,并研究性别、发病年龄以及血糖控制时间与青春期的关系所产生的影响。
在这项基于人群的瑞典队列研究中,我们从国家糖尿病登记处中所有儿童期发病的1型糖尿病患者的专科医疗就诊记录中收集了血糖控制情况和身高数据。我们使用线性回归和逻辑回归,将次优(糖化血红蛋白A1c [HbA1c] 53 - 75 mmol/mol [7.0 - 9.0%])和差(HbA1c > 75 mmol/mol [>9.0%])的血糖控制情况与最佳(HbA1c < 53 mmol/mol [<7.0%])的血糖控制情况进行比较,分析其与最终成人身高和身材矮小风险的关系。
血糖控制差与男性最终成人身高较低(-2.91 cm [95% CI,-3.48至-2.33])以及女性最终成人身高较低(-1.83 cm [-2.42至-1.23])相关,同时男性身材矮小风险较高(比值比1.90 [1.07 - 3.35]),而女性则不然(0.73 [0.36 - 1.51])。对于女性,仅在青春期前就患有1型糖尿病且血糖控制差发生在青春期前的人群中,成人身高较低。对于男性,无论糖尿病发病年龄如何,只要在青春期期间或之后血糖控制差,成人身高就会较低。
与最佳控制相比,1型糖尿病发病后血糖控制差与男性和女性的成人身高较低有关。青春期前时期对女性似乎比对男性更为关键。